Company profile for Eascra Biotech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

​Eascra Biotech is an early-stage nanomedicine company based in Boston, MA, developing Janus Base Nanoparticles (JBNps) inspired by DNA. These non-lipid nanoparticles offer enhanced stability, biocompatibility, and targeted delivery for therapeutics, including RNA, proteins, and small molecules. JBNps can penetrate challenging tissues like cartilage, brain, kidneys, and ECM-rich tumors. Their unique structure minimizes immun...
​Eascra Biotech is an early-stage nanomedicine company based in Boston, MA, developing Janus Base Nanoparticles (JBNps) inspired by DNA. These non-lipid nanoparticles offer enhanced stability, biocompatibility, and targeted delivery for therapeutics, including RNA, proteins, and small molecules. JBNps can penetrate challenging tissues like cartilage, brain, kidneys, and ECM-rich tumors. Their unique structure minimizes immunogenicity and toxicity, enabling room-temperature stability and efficient endocytosis. Eascra collaborates with NASA, the ISS National Lab, and Axiom Space to advance drug delivery solutions for hard-to-treat diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
139A Charles St #315 Boston, MA 02114
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/15/3167326/0/en/Eascra-Biotech-Named-to-Fast-Company-s-Next-Big-Things-in-Tech-2025.html

GLOBENEWSWIRE
15 Oct 2025

https://www.globenewswire.com/news-release/2025/05/19/3083947/0/en/Eascra-Biotech-Awarded-100-000-MassVentures-START-Grant.html

GLOBENEWSWIRE
19 May 2025

https://www.globenewswire.com/news-release/2025/05/01/3072734/0/en/Eascra-Biotech-Expands-Operations-with-a-New-Worcester-Lab.html

GLOBENEWSWIRE
01 May 2025

https://www.globenewswire.com/news-release/2025/04/21/3064673/0/en/Eascra-Biotech-Receives-U-S-National-Science-Foundation-Grant.html

GLOBENEWSWIRE
21 Apr 2025

https://www.globenewswire.com/news-release/2025/04/16/3062864/0/en/Eascra-Biotech-Preparing-for-a-Fifth-Flight-to-the-International-Space-Station.html

GLOBENEWSWIRE
16 Apr 2025

https://www.globenewswire.com/news-release/2023/05/19/2672779/0/en/Eascra-Biotech-Research-Blasts-Off-with-Ax-2-Launch.html

GLOBENEWSWIRE
19 May 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty